VERVE-102

· Verve Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VERVE-102, covering 2026-04-01 to 2026-04-01. Get the full timeline:

Most recent: Clinical Trial Update: A Study of VERVE-102 in Patients With Familial Hypercholesterolemia or Premature Coronary Artery Disease [Phase 1]

See pricing